These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37451553)

  • 21. Factors associated with contingency management adoption among opioid treatment providers receiving a comprehensive implementation strategy.
    Becker SJ; Kelly LM; Kang AW; Escobar KI; Squires DD
    Subst Abus; 2019; 40(1):56-60. PubMed ID: 29595403
    [No Abstract]   [Full Text] [Related]  

  • 22. Nationwide dissemination of contingency management: the Veterans Administration initiative.
    Petry NM; DePhilippis D; Rash CJ; Drapkin M; McKay JR
    Am J Addict; 2014; 23(3):205-10. PubMed ID: 24724876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An unexplored equity factor: differential beliefs and attitudes toward contingency management by providers' ethnicity.
    Oluwoye O; Weeks DL; McDonell MG
    BMC Health Serv Res; 2023 Aug; 23(1):902. PubMed ID: 37612684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spending money to make change: Association of methamphetamine abstinence and voucher spending among contingency management pilot participants in South Africa.
    Krishnamurti T; Ling Murtaugh K; Van Nunen L; Davis AL; Ipser J; Shoptaw S
    J Subst Abuse Treat; 2020 May; 112():60-67. PubMed ID: 32199547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contingency management: an evidence-based component of methamphetamine use disorder treatments.
    Roll JM
    Addiction; 2007 Apr; 102 Suppl 1():114-20. PubMed ID: 17493060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementing an evidence-based prize contingency management protocol for stimulant use.
    Rash CJ
    J Subst Use Addict Treat; 2023 Aug; 151():209079. PubMed ID: 37230390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An autoregressive cross-lagged model unraveling co-occurring stimulant use and HIV: Results from a randomized controlled trial.
    Lee JY; Lee JE; Moskowitz JT; Feaster DJ; Neilands TB; Dilworth SE; Rodriguez A; Carrico AW
    Drug Alcohol Depend; 2021 Aug; 225():108752. PubMed ID: 34144507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contingency management for the treatment of methamphetamine use disorder: A systematic review.
    Brown HD; DeFulio A
    Drug Alcohol Depend; 2020 Nov; 216():108307. PubMed ID: 33007699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effectiveness of Ultra-Low Magnitude Reinforcers: Findings From a "Real-World" Application of Contingency Management.
    Kropp F; Lewis D; Winhusen T
    J Subst Abuse Treat; 2017 Jan; 72():111-116. PubMed ID: 27422452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized controlled trial of a positive affect intervention for methamphetamine users.
    Carrico AW; Gόmez W; Jain J; Shoptaw S; Discepola MV; Olem D; Lagana-Jackson J; Andrews R; Neilands TB; Dilworth SE; Evans JL; Woods WJ; Moskowitz JT
    Drug Alcohol Depend; 2018 Nov; 192():8-15. PubMed ID: 30195243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient characteristics and treatment utilization in fatal stimulant-involved overdoses in the United States Veterans Health Administration.
    Coughlin LN; Zhang L; Bohnert ASB; Maust DT; Goldstick J; Lin LA
    Addiction; 2022 Apr; 117(4):998-1008. PubMed ID: 34648209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine.
    Carrico AW; Neilands TB; Dilworth SE; Evans JL; Gόmez W; Jain JP; Gandhi M; Shoptaw S; Horvath KJ; Coffin L; Discepola MV; Andrews R; Woods WJ; Feaster DJ; Moskowitz JT
    J Int AIDS Soc; 2019 Dec; 22(12):e25436. PubMed ID: 31860172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A community-engaged randomized controlled trial of an integrative intervention with HIV-positive, methamphetamine-using men who have sex with men.
    Carrico AW; Jain J; Discepola MV; Olem D; Andrews R; Woods WJ; Neilands TB; Shoptaw S; Gómez W; Dilworth SE; Moskowitz JT
    BMC Public Health; 2016 Jul; 16():673. PubMed ID: 27476110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between prescription and illicit stimulant and opioid use in the United States, 2015-2020.
    Shearer RD; Jones A; Howell BA; Segel JE; Winkelman TNA
    J Subst Abuse Treat; 2022 Dec; 143():108894. PubMed ID: 36206585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between pre-treatment drug use and heterogeneity of psychiatric diagnosis predicts outcomes in outpatients with co-occurring disorders.
    Oluwoye O; Hirchak K; Leickly E; Skalisky J; McPherson S; Srebnik D; Roll JM; Ries RK; McDonell MG
    Psychiatry Res; 2018 Feb; 260():233-235. PubMed ID: 29220679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining Longitudinal Stimulant Use and Treatment Attendance as Parallel Outcomes in Two Contingency Management Randomized Clinical Trials.
    McPherson S; Brooks O; Barbosa-Leiker C; Lederhos C; Lamp A; Murphy S; Layton M; Roll J
    J Subst Abuse Treat; 2016 Feb; 61():18-25. PubMed ID: 26456717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fourth wave of the overdose crisis: Examining the prominent role of psychomotor stimulants with and without fentanyl.
    Rawson RA; Erath TG; Clark HW
    Prev Med; 2023 Nov; 176():107625. PubMed ID: 37468073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adapting Contingency Management for Hospitalized Patients with Stimulant Use Disorder.
    Peng L; Titus H; Roellich P; Englander H
    J Addict Med; 2023 Sep-Oct 01; 17(5):580-586. PubMed ID: 37788613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.